Th17 cells
Expansion in CD39(+) CD4(+) Immunoregulatory T Cells and Rarity of Th17 Cells in HTLV-1 Infected Patients Is Associated with Neurological Complications
15
Impact of dietary gluten on regulatory T cells and Th17 cells in BALB/c mice.
12
The Role of Regulatory T Cells and TH17 Cells in Multiple Myeloma
5
Protein kinase C θ regulates the phenotype of murine CD4+ Th17 cells.
11
Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis.
13
Photo(chemo)therapy reduces circulating Th17 cells and restores circulating regulatory T cells in psoriasis.
9
C5a regulates IL-12+ DC migration to induce pathogenic Th1 and Th17 cells in sepsis.
8
B cells contribute to heterogeneity of IL-17 producing cells in rheumatoid arthritis and healthy controls.
11
Estudo de alterações em células Treg e TH17 no linfonodo drenante de animais com tumores
71
Induced Treg Cells Augment the Th17-Mediated Intestinal Inflammatory Response in a CTLA4-Dependent Manner.
18
Human dendritic cells activated via dectin-1 are efficient at priming Th17, cytotoxic CD8 T and B cell responses.
8
NKT cell stimulation with α-galactosylceramide results in a block of Th17 differentiation after intranasal immunization in mice.
8
Epstein Barr virus-induced 3 (EBI3) together with IL-12 negatively regulates T helper 17-mediated immunity to Listeria monocytogenes infection.
9
Enhanced Th1/Th17 Functions of CD161+ CD8+ T Cells in Mucosal Tissues of Rhesus Macaques.
16
Braz. j. . vol.80 número2
4
Prognostic Significance of the Systemic Inflammatory and Immune Balance in Alcoholic Liver Disease with a Focus on Gender-Related Differences.
19
The Circulating Treg/Th17 Cell Ratio Is Correlated with Relapse and Treatment Response in Pulmonary Sarcoidosis Patients after Corticosteroid Withdrawal.
19
Expression of VSTM1-v2 Is Increased in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Is Correlated with Disease Activity.
9
The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans.
10
Th17/IL-17A might play a protective role in chronic lymphocytic leukemia immunity.
8